Mimedx (MDXG) Other Non-Current Liabilities (2011 - 2026)
Mimedx's (MDXG) quarterly Other Non-Current Liabilities came in at $10.8 million in Q2 2026, up 54.51% year-over-year from $7.0 million in Q2 2025, and up 111.75% quarter-over-quarter from $5.1 million in Q1 2026.
Analysis
Mimedx (MDXG) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Mimedx has disclosed Other Non-Current Liabilities across 16 years of filings, most recently posting $10.8 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 54.51% year-over-year to $10.8 million; the TTM figure through Jun 2026 stood at $10.8 million (up 54.51% YoY), while the FY2025 annual figure was $5.4 million, down 27.24% from the prior year.
- Other Non-Current Liabilities came in at $10.8 million for Q2 2026 at Mimedx, up from $5.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $10.8 million in Q2 2026 to a low of $2.2 million in Q4 2023.
- Average Other Non-Current Liabilities over 5 years is $5.1 million, with a median of $4.9 million recorded in 2022.
- Year-over-year, Other Non-Current Liabilities tumbled 53.43% in 2023 and soared 232.12% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $4.8 million in 2022, then plunged by 53.43% to $2.2 million in 2023, then soared by 232.12% to $7.4 million in 2024, then fell by 27.24% to $5.4 million in 2025, then jumped by 100.87% to $10.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $10.8 million in Q2 2026, $5.1 million in Q1 2026, and $5.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn |
| 10 | Mimedx | 667.30 Mn | 531.46 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.79 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 7.49 Mn |
| Dec 31, 2024 | 7.38 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 4.03 Mn |
| Dec 31, 2022 | 4.77 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Mar 31, 2022 | 4.55 Mn |
| Dec 31, 2021 | 4.87 Mn |
| Sep 30, 2021 | 4.08 Mn |